
Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data
Author(s) -
Kathleen Mortimer,
Dorothee B. Bartels,
N Hartmann,
Jorge Capapey,
Jing Yang,
Robert Gately,
Cheryl Enger
Publication year - 2020
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000504630
Subject(s) - medicine , idiopathic pulmonary fibrosis , cohort , incidence (geometry) , interstitial lung disease , disease , pulmonary hypertension , gastroenterology , lung , physics , optics
Idiopathic pulmonary fibrosis (IPF) is a life-threatening interstitial lung disease (ILD). Characterizing health outcomes of IPF patients is challenging due to disease rarity.